Clover Health Investments, Corp.
CLOV
$3.60
$0.010.28%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 49.24% | 40.66% | 31.76% | 21.89% | 15.34% |
| Total Other Revenue | 18.42% | 23.24% | 50.38% | 36.27% | 33.21% |
| Total Revenue | 48.69% | 40.33% | 32.09% | 22.12% | 15.62% |
| Cost of Revenue | 64.86% | 55.85% | 38.00% | 22.54% | 10.01% |
| Gross Profit | 3.53% | -2.53% | 13.92% | 20.78% | 34.80% |
| SG&A Expenses | 11.31% | 7.53% | 7.44% | 2.79% | -0.62% |
| Depreciation & Amortization | 17.31% | 26.67% | -3.07% | -17.88% | -41.95% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 50.06% | 41.82% | 29.22% | 16.72% | 6.78% |
| Operating Income | -133.43% | -86.22% | 22.55% | 56.27% | 81.13% |
| Income Before Tax | -133.65% | -84.91% | 37.77% | 64.17% | 84.14% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -133.65% | -84.91% | 37.77% | 64.17% | 84.14% |
| Earnings from Discontinued Operations | -- | -- | -145.56% | 84.03% | 88.22% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -126.74% | -98.91% | 36.18% | 65.16% | 84.30% |
| EBIT | -133.43% | -86.22% | 22.55% | 56.27% | 81.13% |
| EBITDA | -140.92% | -88.00% | 22.99% | 57.02% | 81.92% |
| EPS Basic | -118.43% | -89.41% | 38.79% | 66.12% | 84.64% |
| Normalized Basic EPS | -124.52% | -77.00% | 25.73% | 57.47% | 81.53% |
| EPS Diluted | -104.13% | -79.78% | 40.28% | 66.73% | 83.23% |
| Normalized Diluted EPS | -123.08% | -76.40% | 25.88% | 57.54% | 81.41% |
| Average Basic Shares Outstanding | 4.81% | 4.10% | 3.34% | 2.68% | 2.01% |
| Average Diluted Shares Outstanding | 4.40% | 3.69% | 2.94% | 2.27% | 2.41% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |